Case Studies
Key developments in the modernisation of Chinese Medicine through significant research advances at Hong Kong Baptist University and beyond include standardised reporting guidelines, clinical protocols, novel drug delivery mechanisms, and the application of molecular pharmacognosy. These innovations have enhanced research quality, validated traditional practices, and facilitated the integration of Chinese Medicine into contemporary healthcare systems.
Case 1: Advancing methodologies: randomised controlled trials in Chinese Medicine research
Recent advances in randomised controlled trial design have enabled a more clinical and rigourous evaluation of Chinese Medicine, with several high-profile studies demonstrating both efficacy and safety in conditions like heart failure and diabetic kidney disease.
Case 2: Integrative approaches to Chinese Medicine formulae: from clinical validation to scientific insights
Key findings reveal that modern scientific research is transforming the understanding of Chinese Medicine formulae (CMFs) through advanced technologies and clinical validation. Studies demonstrate CMFs’ effectiveness in treating various diseases through multiple bioactive compounds working synergistically, while omics technologies and bioinformatics provide deeper insights into their complex mechanisms and therapeutic effects.
Case 3: Resource sustainability: the role of molecular pharmacognosy and national surveys
Molecular pharmacognosy bridges Chinese materia medica with modern molecular biology, enhancing the scientific investigation and modernisation of Chinese Medicine. The Chinese government’s Fourth National Survey of Chinese materia medica (2011–2020), along with recent advances in molecular biology, provides deeper insights into the genetic and evolutionary history of medicinal plants, thereby integrating traditional knowledge with modern science.
Case 4: Bridging tradition and innovation: advancements in polysaccharide research
The study of Professor Han Quanbin’s team from Hong Kong Baptist University reveals a groundbreaking discovery of RAP, a novel polysaccharide from huangqi, which effectively enters the lymphatic system through M-cell transport.
Case 5: Advancing Chinese Medicine: HKBU's pioneering contributions in reporting and clinical guidelines
Hong Kong Baptist University researchers have made significant contributions to modernising Chinese Medicine through the development of comprehensive reporting guidelines and clinical practice protocols.